Inhibition of IL-1B in metastatic breast cancer cells resulted in no chemokine production by MSCs, whereas overexpression of IL-1B in non-metastatic breast cancer cells increased chemokine levels in MSCs. The gene discussed is IL1B; the disease is breast carcinoma.